Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04807816
Title Targeting ATR in Soft-tissue Sarcomas (TARSARC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié
Indications

leiomyosarcoma

Therapies

Berzosertib + Gemcitabine

Gemcitabine

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.